Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

2046.75 (Glytoucan)

Id:c244ec11-076c-5182-8f7f-5028891fa5a2

Glytoucan:G84276MU

Results found

Linked to

	Label	Description
	2046.75 has glycosequence GLYGEN.GLYCOSEQUENCE:G89797XK-GLYCOSEQ00065076 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2046.75 has glycosequence GLYGEN.GLYCOSEQUENCE:G96919WB-GLYCOSEQ00000296 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2046.75 has glycosequence GLYGEN.GLYCOSEQUENCE:G43433FA-GLYCOSEQ00025766 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2046.75 has glycosequence GLYGEN.GLYCOSEQUENCE:G46112FO-GLYCOSEQ00180819 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2046.75 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000003 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2046.75 has glycosequence GLYGEN.GLYCOSEQUENCE:G74574VX-GLYCOSEQ00077599 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2046.75 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000083 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2046.75 has glycosequence GLYGEN.GLYCOSEQUENCE:G06430FC-GLYCOSEQ00070723 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2046.75 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000021 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2046.75 has canonical residue n-glycan b-d-galp 6 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2046.75 has glycosequence GLYGEN.GLYCOSEQUENCE:G89797XK-GLYCOSEQ00065076 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2046.75 has glycosequence GLYGEN.GLYCOSEQUENCE:G96919WB-GLYCOSEQ00000296 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2046.75 has glycosequence GLYGEN.GLYCOSEQUENCE:G43433FA-GLYCOSEQ00025766 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2046.75 has glycosequence GLYGEN.GLYCOSEQUENCE:G46112FO-GLYCOSEQ00180819 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2046.75 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000003 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2046.75 has glycosequence GLYGEN.GLYCOSEQUENCE:G74574VX-GLYCOSEQ00077599 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2046.75 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000083 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2046.75 has glycosequence GLYGEN.GLYCOSEQUENCE:G06430FC-GLYCOSEQ00070723 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2046.75 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000021 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2046.75 has canonical residue n-glycan b-d-galp 6

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.